| Justin Elan Palm, DO | |
|
Misawa Air Base 35th Mdg Flight, Building 99, Unit 5024, Apo, AP 96319 | |
| (017) 677-6133 | |
| Not Available |
| Full Name | Justin Elan Palm |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Misawa Air Base 35th Mdg Flight, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215682943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | DR.0071574 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Justin Elan Palm, DO Building 99, Unit 5024, Misawa Air Base, Apo, AP 96319 Ph: (017) 677-6133 | Justin Elan Palm, DO Misawa Air Base 35th Mdg Flight, Building 99, Unit 5024, Apo, AP 96319 Ph: (017) 677-6133 |
News Archive
In the field of hepatic imaging in the context of living liver donors and before complex partial liver resections, three-dimensional imaging of the liver, hepatic vessels and bile ducts has managed to become established in some centers. In this case, in addition to visualization, the volumetry of various liver sections is of interest. Moreover, the three-dimensional reconstruction can be used preoperatively to consider various resection options and to evaluate their technical feasibility with regard to vascular and bile duct anatomy and to the expected liver volume after surgery.
Taking aim at the fundamental biology of cancer cells, the National Institutes of Health has awarded $747,000 to Worcester Polytechnic Institute for a three-year research project to explore the molecular mechanisms associated with the genetic mutations and chromosome instability observed in all cancer cells.
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The results suggest that the method might lead to more optimal treatment of individual patients.
Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.
Overreaction is rarely useful, and in the case of the human immune system, it can be outright deadly. When the body overreacts to an infection, the result is sepsis - a life-threatening condition that frequently leads to acute organ dysfunction, including deterioration of the heart and blood vessels, which make up the cardiovascular system.
› Verified 2 days ago
Sarah Mcdonald, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 445-630-4089 | |
Jonathan Hajduk, DO General Practice Medicare: Medicare Enrolled Practice Location: Psc 2, Apo, AP 96264 Phone: 315-782-8035 | |
Francesann Hill, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3214 East Santiago Avenue, Apo, AP 99703 Phone: 907-353-2497 | |
Ms. Maryrose Delgallego Chuidian, DO General Practice Medicare: Medicare Enrolled Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 315-630-4780 | |
Dr. Adriana Zamora, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Building 99 Unit 5024, Misawa Ab, Japan, Apo, AP 96319 Phone: 315-226-6133 | |
Dr. Timothy A Gocke, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 549th Hospital Center, Apo, AP 96271 Phone: 315-737-1131 |